Pubblicazioni

NfL levels predominantly increase at disease onset in MOG-Abs-associated disorders  (2021)

Autori:
Mariotto, Sara; Gastaldi, Matteo; Grazian, Luisa; Mancinelli, Chiara; Capra, Ruggero; Marignier, Romaine; Alberti, Daniela; Zanzoni, Serena; Schanda, Kathrin; Franciotta, Diego; Calabria, Francesca; Monaco, Salvatore; Reindl, Markus; Ferrari, Sergio; Gajofatto, Alberto
Titolo:
NfL levels predominantly increase at disease onset in MOG-Abs-associated disorders
Anno:
2021
Tipologia prodotto:
Articolo in Rivista
Tipologia ANVUR:
Articolo su rivista
Lingua:
Inglese
Formato:
Elettronico
Referee:
Nome rivista:
MULTIPLE SCLEROSIS AND RELATED DISORDERS
ISSN Rivista:
2211-0348
N° Volume:
50
Numero o Fascicolo:
102833
Intervallo pagine:
1-4
Parole chiave:
MOG; MOGAD; Myelitis; Neurofilament light chain levels; NfL; Optic neuritis
Breve descrizione dei contenuti:
The unpredictable course and uncertain impact of relapses make treatment strategies of anti-myelin oligodendrocyte glycoprotein antibodies associated disorders (MOGAD) challenging. We analysed neurofilament light chain levels (NfL) in onset and follow-up sera of 18 patients with MOGAD to clarify the timing of axonal damage. In comparison with disease onset values (median 8.9 pg/mL, range 1.8-97), NfL levels remained stable or decreased in most follow-up measurements (n=52, median 6.7 pg/mL, range 0.2-207), including those measured on relapses. The predominant axonal damage occurs during onset, which could be the main driving factor of final disability, with subsequent relevant clinical and therapeutic implications.
Pagina Web:
https://doi.org/10.1016/j.msard.2021.102833
Id prodotto:
119504
Handle IRIS:
11562/1037061
ultima modifica:
9 novembre 2022
Citazione bibliografica:
Mariotto, Sara; Gastaldi, Matteo; Grazian, Luisa; Mancinelli, Chiara; Capra, Ruggero; Marignier, Romaine; Alberti, Daniela; Zanzoni, Serena; Schanda, Kathrin; Franciotta, Diego; Calabria, Francesca; Monaco, Salvatore; Reindl, Markus; Ferrari, Sergio; Gajofatto, Alberto, NfL levels predominantly increase at disease onset in MOG-Abs-associated disorders «MULTIPLE SCLEROSIS AND RELATED DISORDERS» , vol. 50 , n. 1028332021pp. 1-4

Consulta la scheda completa presente nel repository istituzionale della Ricerca di Ateneo IRIS

<<indietro

Attività

Strutture

Condividi